BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
BioCardia, Inc. (BCDA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $44.70 per share as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $44.70.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $48.34.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $52.80.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $55.74.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $44.70 10-Q · filed 2026-08-12 |
| 2026-03-31 | $48.34 10-Q · filed 2026-05-15 |
| 2025-12-31 | $52.80 10-K · filed 2026-03-24 |
| 2025-09-30 | $55.74 10-Q · filed 2025-11-12 |
| 2025-06-30 | $56.93 10-Q/A · filed 2025-10-29 |
| 2025-03-31 | $58.07 10-Q · filed 2025-05-14 |
| 2024-12-31 | $59.49 10-K · filed 2025-03-26 |
| 2024-09-30 | $63.83 10-Q · filed 2024-11-13 |
| 2024-06-30 | $65.79 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.49 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.56 10-K · filed 2024-03-27 |
| 2023-09-30 | $4.61 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.83 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.27 10-Q · filed 2023-05-10 |
| 2022-12-31 | $5.48 10-K · filed 2023-03-29 |
| 2022-09-30 | $5.70 10-Q · filed 2022-11-09 |
| 2022-06-30 | $5.99 10-Q · filed 2022-08-10 |
| 2022-03-31 | $6.46 10-Q · filed 2022-05-11 |
| 2021-12-31 | $6.62 10-K · filed 2022-03-29 |
| 2021-09-30 | $6.91 10-Q · filed 2021-11-10 |
| 2021-06-30 | $7.13 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.29 10-Q · filed 2021-05-13 |
| 2020-12-31 | $7.51 10-K · filed 2021-03-30 |
| 2020-09-30 | $7.77 10-Q · filed 2020-11-10 |
| 2020-06-30 | $8.05 10-Q · filed 2020-08-13 |
| 2020-03-31 | $8.63 10-Q · filed 2020-05-15 |
| 2019-12-31 | $23.62 10-K · filed 2020-04-09 |
| 2019-09-30 | $24.17 10-Q · filed 2019-11-19 |
| 2019-06-30 | $24.57 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.71 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.72 10-K · filed 2019-04-02 |
| 2017-12-31 | $2.28 10-K · filed 2018-03-16 |
| 2016-12-31 | $0.14 10-K · filed 2017-03-30 |
| 2016-09-30 | $0.23 10-Q · filed 2016-10-17 |
| 2016-06-30 | $0.23 10-Q · filed 2016-08-02 |
| 2016-03-31 | $0.23 10-Q · filed 2016-05-03 |
| 2015-12-31 | $0.23 10-K · filed 2016-03-25 |
| 2015-09-30 | $0.23 10-Q · filed 2015-10-29 |
| 2015-03-31 | $0.23 10-Q · filed 2015-05-12 |
| 2014-12-31 | $0.23 10-Q · filed 2015-08-12 |
| 2014-09-30 | $0.23 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.23 10-Q · filed 2014-08-06 |
| 2014-03-31 | $0.23 10-Q · filed 2014-05-12 |
| 2012-12-31 | $0.23 10-K · filed 2014-03-24 |
| 2012-09-30 | $0.23 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.23 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |